These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture. Boudon C, Rodier G, Lechevallier E, Mottet N, Barenton B, Sultan C. J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277 [Abstract] [Full Text] [Related]
3. Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization. Barni T, Vannelli BG, Sadri R, Pupilli C, Ghiandi P, Rizzo M, Selli C, Serio M, Fiorelli G. J Clin Endocrinol Metab; 1994 Mar; 78(3):778-83. PubMed ID: 7510307 [Abstract] [Full Text] [Related]
4. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues. Cohen P, Nunn SE, Peehl DM. J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857 [Abstract] [Full Text] [Related]
5. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia. Dong G, Rajah R, Vu T, Hoffman AR, Rosenfeld RG, Roberts CT, Peehl DM, Cohen P. J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294 [Abstract] [Full Text] [Related]
6. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens. Monti S, Di Silverio F, Iraci R, Martini C, Lanzara S, Falasca P, Poggi M, Stigliano A, Sciarra F, Toscano V. J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606 [Abstract] [Full Text] [Related]
7. Insulin-like growth factor-binding proteins in R3230AC mammary tumors of intact and diabetic rats. Korc-Grodzicki B, Ren N, Hilf R. Endocrinology; 1993 Nov; 133(5):2362-70. PubMed ID: 7691588 [Abstract] [Full Text] [Related]
8. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells. Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS. J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546 [Abstract] [Full Text] [Related]
9. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. el-Roeiy A, Chen X, Roberts VJ, Shimasakai S, Ling N, LeRoith D, Roberts CT, Yen SS. J Clin Endocrinol Metab; 1994 Jun; 78(6):1488-96. PubMed ID: 7515389 [Abstract] [Full Text] [Related]
10. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines. Noll K, Wegmann BR, Havemann K, Jaques G. J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593 [Abstract] [Full Text] [Related]
11. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors. McCarthy TL, Casinghino S, Centrella M, Canalis E. J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403 [Abstract] [Full Text] [Related]
12. Gene expression of insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Price WA, Stiles AD, Moats-Staats BM, D'Ercole AJ. Endocrinology; 1992 Mar; 130(3):1424-32. PubMed ID: 1371449 [Abstract] [Full Text] [Related]
13. Reduction of insulin-like growth factor-I (IGF-I) in protein-restricted rats is associated with differential regulation of IGF-binding protein messenger ribonucleic acids in liver and kidney, and peptides in liver and serum. Lemozy S, Pucilowska JB, Underwood LE. Endocrinology; 1994 Aug; 135(2):617-23. PubMed ID: 7518385 [Abstract] [Full Text] [Related]
14. Regulation of insulin-like growth factor-binding protein-4 in human endometrial stromal cell cultures: evidence for ligand-induced proteolysis. Irwin JC, Dsupin BA, Giudice LC. J Clin Endocrinol Metab; 1995 Feb; 80(2):619-26. PubMed ID: 7531715 [Abstract] [Full Text] [Related]
15. Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. Vollenhoven BJ, Herington AC, Healy DL. J Clin Endocrinol Metab; 1993 May; 76(5):1106-10. PubMed ID: 7684390 [Abstract] [Full Text] [Related]
16. Hormonal regulation of astroglial insulin-like growth factor (IGF)-binding protein gene expression by IGFs and insulin. Bradshaw SL, Han VK. Endocrinology; 1993 Oct; 133(4):1767-77. PubMed ID: 7691580 [Abstract] [Full Text] [Related]
20. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Le H, Arnold JT, McFann KK, Blackman MR. Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782 [Abstract] [Full Text] [Related] Page: [Next] [New Search]